NeuroOne Medical Technologies: Key Insights from February 2025 8-K Report

Based on the provided section of the financial report, here are the key insights and information extracted:
- Entity Information:
- Company Name: NeuroOne Medical Technologies Corporation
- CIK: 0001500198
- SEC File Number: 001-40439
- EIN: 27-0863354
- Address: 7599 Anagram Dr., Eden Prairie, MN 55344
- Contact Number: 952-426-1383
- Ticker Symbol: NMTC
- Exchange: NASDAQ
- Filing Details:
- Filing Type: 8-K
- Filing Date: February 14, 2025
- Financial Metrics:
- Common Stock Par Value: $0.001 per share
- Context and Units:
- The report is associated with a specific period starting and ending on February 14, 2025.
- The financial data is reported in USD (U.S. Dollars) and shares, indicating that the company is likely disclosing information related to its common stock.
- Schema Reference:
- The filing refers to a specific schema file (
nmtc-20250214.xsd
), indicating the structure and format of the data presented in the filing.
Summary
This section of the financial report provides basic corporate and filing details, including the company’s identification, contact information, and the specifics of the financial disclosure. The information suggests that NeuroOne Medical Technologies Corporation is filing an 8-K report, likely to disclose significant events or changes relevant to its business as of the specified date.